Purple Biotech Ltd
PPBT
$2.99
$0.072.40%
NASDAQ
| 12/31/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | ||
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -- | -- | -- | -- | |
| Cost of Revenue | -- | 62.00K | 62.00K | 62.00K | |
| Gross Profit | -- | -62.00K | -62.00K | -62.00K | |
| SG&A Expenses | -- | 2.61M | 2.79M | 3.19M | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | -- | 5.79M | 7.81M | 10.87M | |
| Operating Income | -- | -5.79M | -7.81M | -10.87M | |
| Income Before Tax | -- | -2.63M | -3.95M | -7.28M | |
| Income Tax Expenses | -- | -- | -- | -- | |
| Earnings from Continuing Operations | -- | -2.63 | -3.95 | -7.28 | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | 17.00K | 23.00K | 39.00K | |
| Net Income | -- | -2.61M | -3.93M | -7.24M | |
| EBIT | -- | -5.79M | -7.81M | -10.87M | |
| EBITDA | -- | -5.64M | -7.66M | -10.72M | |
| EPS Basic | -- | -0.01 | -0.01 | -0.03 | |
| Normalized Basic EPS | -- | 0.00 | -0.01 | -0.01 | |
| EPS Diluted | -- | -0.01 | -0.01 | -0.03 | |
| Normalized Diluted EPS | -- | 0.00 | -0.01 | -0.01 | |
| Average Basic Shares Outstanding | -- | 1.83B | 1.56B | 1.30B | |
| Average Diluted Shares Outstanding | -- | 1.83B | 1.56B | 1.30B | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |